Fig. 1From: Evolving prevalence of haematological malignancies in orphan designation procedures in the European UnionDistribution of all orphan designations for haematological malignancies in oncology 2000–2015 (Percentage details: AML 9,6%; MM 6%; ALL 5%; CLL/SLL 5%; CDCL 3%; MDS 2%)Back to article page